StageZero Life Sciences Ltd.
SZLSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4,405 | $16,265 | $26,220 | $757 |
| - Cash | $16 | $1,725 | $6,597 | $71 |
| + Debt | $1,800 | $1,356 | $3,570 | $2,459 |
| Enterprise Value | $6,189 | $15,896 | $23,193 | $3,145 |
| Revenue | $3,795 | $5,068 | $4,152 | $139 |
| % Growth | -25.1% | 22.1% | 2,893.3% | – |
| Gross Profit | -$404 | $1,177 | $696 | -$961 |
| % Margin | -10.6% | 23.2% | 16.8% | -692.8% |
| EBITDA | -$10,270 | -$5,686 | -$6,259 | -$2,436 |
| % Margin | -270.6% | -112.2% | -150.7% | -1,756.2% |
| Net Income | -$11,415 | -$7,484 | -$6,864 | -$3,482 |
| % Margin | -300.8% | -147.7% | -165.3% | -2,510.2% |
| EPS Diluted | -0.11 | -0.1 | -0.15 | -0.16 |
| % Growth | -10% | 33.3% | 6.3% | – |
| Operating Cash Flow | -$3,529 | -$8,955 | -$3,064 | -$4,591 |
| Capital Expenditures | $0 | -$148 | -$72 | -$44 |
| Free Cash Flow | -$3,529 | -$9,103 | -$3,137 | -$4,635 |